Afrobodies
OperatingSouth African biotech producing single-domain antibodies from alpacas, including antibodies against SARS-CoV-2.
- Employees
- 2-10
About Afrobodies
Afrobodies is a Cape Town-based biotechnology company that produces single-domain antibodies derived from alpacas. It publishes a product list of antibodies available to research and industry customers.
The company's Covid-19 antibody project produced antibodies that neutralized the live SARS-CoV-2 501Y.V2 variant, known as the "SA variant". This result was independently verified by the Africa Health Research Institute at the University of KwaZulu-Natal. Afrobodies operates from Cape Town, South Africa, and shares updates through a news and media section on its website.
More Biotechnology startups in South Africa
- Cabal
South African bio-intelligence platform combining AI plant identification with indigenous knowledge and conservation data. · South Africa
- API BIO
South African biotech preparing to launch work in biostimulants, food crops, nanotech diagnostics and aptamer technology. · South Africa
- Labstudio LIMS
Laboratory information management software for desktop with cloud or on-premises databases and custom modules · South Africa
- Amesect
Insect biotechnology company using black soldier fly systems to turn organic waste into high-value biological products. · South Africa
- Nothile Biolab
Virtual lab platform that trains African scientists in biotech skills such as cell culture at lower cost · South Africa
- LIQID Medical
Clinical-stage Cape Town medtech company developing QMAX, a surgical implant that treats glaucoma as a two-pressure disease · South Africa
Frequently asked about Afrobodies
- Where is Afrobodies based and when was it founded?
- Afrobodies is headquartered in Capetown, South Africa and was founded in 2016.
- What sector is Afrobodies in?
- Afrobodies operates in Biotechnology and HealthTech.
